Kymera Therapeutics, Inc. (KYMR)
114.96
-2.04
(-1.74%)
USD |
NASDAQ |
Sep 11, 16:00
114.90
-0.06
(-0.05%)
After-Hours: 05:20
Kymera Therapeutics Price : 114.96 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 118.40 | 119.93 | 113.74 | 114.96 | 574186.0 |
| Sep 10, 2026 | 116.05 | 119.63 | 114.35 | 117.00 | 734300.0 |
| Sep 09, 2026 | 115.34 | 120.66 | 113.18 | 115.43 | 767425.0 |
| Sep 08, 2026 | 114.41 | 120.22 | 113.97 | 116.47 | 631822.0 |
| Sep 04, 2026 | 115.09 | 118.28 | 112.77 | 117.39 | 378568.0 |
| Sep 03, 2026 | 118.63 | 119.26 | 115.55 | 117.28 | 591615.0 |
| Sep 02, 2026 | 119.58 | 123.54 | 117.42 | 118.63 | 982968.0 |
| Sep 01, 2026 | 116.92 | 119.78 | 116.28 | 119.05 | 576626.0 |
| Aug 31, 2026 | 118.60 | 119.93 | 115.97 | 118.81 | 656834.0 |
| Aug 28, 2026 | 119.40 | 121.98 | 117.48 | 118.15 | 415947.0 |
| Aug 27, 2026 | 124.99 | 125.06 | 119.98 | 120.23 | 595696.0 |
| Aug 26, 2026 | 126.24 | 126.32 | 123.39 | 125.55 | 558343.0 |
| Aug 25, 2026 | 122.64 | 127.85 | 121.60 | 126.64 | 925754.0 |
| Aug 24, 2026 | 119.98 | 121.56 | 116.46 | 121.05 | 466859.0 |
| Aug 21, 2026 | 122.87 | 125.71 | 119.77 | 119.80 | 503430.0 |
| Aug 20, 2026 | 124.95 | 125.45 | 121.13 | 121.50 | 580746.0 |
| Aug 19, 2026 | 124.63 | 127.36 | 121.82 | 127.31 | 842927.0 |
| Aug 18, 2026 | 119.75 | 122.14 | 118.09 | 121.38 | 640892.0 |
| Aug 17, 2026 | 117.39 | 122.59 | 117.04 | 121.41 | 704715.0 |
| Aug 14, 2026 | 112.90 | 118.04 | 110.05 | 117.39 | 468580.0 |
| Aug 13, 2026 | 114.73 | 114.73 | 112.44 | 114.42 | 481718.0 |
| Aug 12, 2026 | 110.22 | 115.00 | 109.08 | 114.03 | 961008.0 |
| Aug 11, 2026 | 108.79 | 110.37 | 106.30 | 109.62 | 2.380M |
| Aug 10, 2026 | 106.63 | 109.05 | 106.04 | 108.58 | 404887.0 |
| Aug 07, 2026 | 106.61 | 108.12 | 104.78 | 107.52 | 463575.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.85 |
| Oncolytics Biotech, Inc. | 0.7455 |
| Sangamo Therapeutics, Inc. | 0.1485 |
| Sarepta Therapeutics, Inc. | 20.45 |
| Anixa Biosciences, Inc. | 2.76 |
Price Related Metrics
| PS Ratio | 102.08 |
| Price to Book Value | 6.306 |
| Earnings Yield | -2.82% |
| Market Cap | 9.517B |